Overview
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 14, 2021 | Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund | Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics that restore ABC transporter function, today announced it has closed a $100 million Series A... |
| Oct 14, 2021 | Atlas Venture-incubated Rectify lands $100M to transport drug hunt to new grounds | One of the quirks about drug hunting is that finding new medicines doesn’t always mean uncovering something completely new. Sometimes it’s about revisiting previously hunted grounds and spotting something that was missed. Rectify Pharmaceut... |
| Sep 17, 2020 | Here are the 19 companies presenting at Alchemist Accelerator Demo Day XXV today | When Alchemist Accelerator shifted its Demo Day to virtual earlier this year, Alchemist director and founder Ravi Belani told me it was a move he expected the team to stick with for some time. Nearly half a year later it’s time for another ... |
| Oct 2, 2018 | The Mentor Method and Rectify Win Capital Factory’s $100,000 Awards at the Women in Tech Summit |
Reviews 0
FAQ about Rectify
What has the press written about Rectify?
Parsers VC has collected 5 articles mentioning Rectify, among them “Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund” (Oct 14, 2021) and “Atlas Venture-incubated Rectify lands $100M to transport drug hunt to new grounds” (Oct 14, 2021).
Is Rectify still active?
Yes, Rectify is active; its latest activity on Parsers VC dates from Oct 14, 2021.